NASDAQ: LICNLichen China Ltd Stock
$1.01+0.06 (+6.32%)
Updated Apr 19, 2024
LICN Price
$1.01
Fair Value Price
N/A
Market Cap
$26.63M
52 Week Low
$0.63
52 Week High
$3.54
P/E
3.14x
P/B
0.43x
P/S
1.3x
PEG
0.08x
Dividend Yield
N/A
Revenue
$39.76M
Earnings
$8.34M
Gross Margin
61.2%
Operating Margin
29.15%
Profit Margin
21%
Debt to Equity
0.07
Operating Cash Flow
$557k
Beta
0.39
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
LICN Overview
Lichen China Limited, an investment holding company, provides financial and taxation, education support, and software and maintenance services in the People's Republic of China. The company offers financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation services; and education support services, including marketing, operational, and technical support, as well as sale of teaching and learning materials. It also provides Lichen Education Accounting Practice System V1.0, a financial and taxation training software, and academic affairs management system to partnered institutions under the partnership agreements, as well as offers software installation, training, and after sales technical and maintenance support services. The company was founded in 2004 and is based in Jinjiang, China. Lichen China Limited operates as a subsidiary of Silver Sky Investment Limited
Zen Score
–
Industry Average (31)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how LICN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
LICN ($1.01) is trading below its intrinsic value of $6.02, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
LICN is good value based on its earnings relative to its share price (3.14x), compared to the US market average (40.51x)
P/E vs Market Valuation
LICN is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more LICN due diligence checks available for Premium users.
Be the first to know about important LICN news, forecast changes, insider trades & much more!
LICN News
Valuation
LICN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
3.14x
Industry
34.35x
Market
40.51x
LICN is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
LICN is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
LICN price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.43x
Industry
4.69x
LICN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
LICN price to earnings growth (PEG)
For valuing profitable companies with growth potential
LICN is good value based... subscribe to Premium to read more.
PEG Value Valuation
LICN's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
LICN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
LICN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$65.5M
Liabilities
$4.1M
Debt to equity
0.07
LICN's short-term assets ($40.13M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
LICN's short-term assets ($40.13M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
LICN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
LICN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
LICN vs Specialty Business Service Stocks
Lichen China Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.